Clinical Trial Update: Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophrenia [NA]

View source ↗

Summary

This clinical trial update reports the completion of a bioequivalence study of long-acting paliperidone palmitate in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone palmitate (long-acting) (paliperidone palmitate)

Snippet

Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Conditions: Schizophrenia | NA | Status: COMPLETED